Director/PDMR Shareholding
Optima Health PLC announced that following the Admission of Open Offer shares on April 23, 2026, six Directors and PDMRs subscribed for an aggregate of 51,560 Open Offer Shares at 175 pence per share, representing approximately 0.05% of the Company's enlarged issued share capital. This transaction involved the purchase of ordinary shares by individuals including the Non-Executive Chairman, Chief Executive Officer, Chief Financial Officer, and other Non-Executive Directors and a Chief Commercial Officer.
Select text to share a quote on X · sign in to keep highlights & notes in your OPT notes
Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, announces that following Admission of the Open Offer shares on 23 April 2026, the Directors / PDMRs, Julie Robertson, Jonathan Thomas, Heidi Giles, Simon Arnold, Adam Councell and Joanne Newey have subscribed for an aggregate of 51,560 Open Offer Shares, representing approximately 0.05% of the Company's enlarged issued share capital.
Details of the Ordinary Shares held by each of the Directors/PDMRs are detailed below:
| Director/PDMR | Current shareholding | % of issued share capital | Shareholding immediately following Admission | % of the enlarged issued share capital following Admission |
|---|---|---|---|---|
| Julia Robertson | 21,500 Ordinary Shares | 0.02 | 26,343 | 0.02 |
| Jonathan Thomas | 218,356 Ordinary Shares | 0.25 | 229,856 | 0.21 |
| Heidi Giles | 83,228 Ordinary Shares | 0.09 | 92,000 | 0.08 |
| Simon Arnold | 20,451 Ordinary Shares | 0.02 | 32,100 | 0.03 |
| Adam Councell | 34,608 Ordinary Shares | 0.04 | 42,404 | 0.04 |
| Joanne Newey | 84,080 Ordinary Shares | 0.09 | 91,080 | 0.08 |
Capitalised terms used but not defined in this announcement shall have the meaning ascribed to such terms in the Circular unless the context requires otherwise.
Optima Health Jonathan Thomas, CEO Heidi Giles, CFO +44(0) 33 0008 5113 media@OptimaHealth.co.uk Nominated Adviser and Joint Corporate Broker Panmure Liberum Limited Emma Earl / Will Goode/ Mark Rogers Rupert Dearden Debt Advisory (sole debt adviser on the transaction): Dan Howlett / Ben Handler +44 (0)20 3100 2000 Joint Corporate Broker Cavendish Capital Markets Geoff Nash / Ben Jeynes / George Lawson Julian Morse / Michael Johnson/ Nigel Birks + 44 (0)20 7220 0500 UK Financial PR Adviser ICR Healthcare Mary-Jane Elliott / Angela Gray / Lindsey Neville optimahealth@icrinc.com
| 2 | Reason for the notification | |
| a) | Position/status | 1. Non-Executive Chairman 2. Chief Executive Officer 3. Chief Financial Officer 4. Non-Executive Director 5. Non-Executive Director 6. Chief Commercial Officer (PDMR) |
| b) | Initial notification /Amendment | Initial notification |
| a) | Name | Optima Health plc |
| b) | LEI | 213800TOPWJSRCW4ON08 |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each |
| Identification code | GB00BRSCY602 | |
| b) | Nature of the transaction | Purchase of shares |
| c) | Price(s) and volume(s) | |
| Purchase Price | Volume | |
| 175 pence per Ordinary Share | 1. 4,843 2. 11,500 3. 8,772 4. 11,649 5. 7,796 6. 7,000 | |
| d) | Aggregated information | |
| - Aggregated volume | 51,560 shares | |
| 175.00 pence | ||
| - Price | ||
| e) | Date of the transaction | 23 April 2026 |
| f) | Place of the transaction | London Stock Exchange, AIM Market |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.